Compare Mandala Multifinance Tbk. (MFIN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mandala Multifinance Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mandala Multifinance Tbk. trades at Rp890 (market cap 4.45T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mandala Multifinance Tbk. is far larger — about 42.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MFIN | SCPI | |
|---|---|---|
Market Cap | 4.45T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mandala Multifinance Tbk.
PT Mandala Multifinance Tbk (the Company) was established under its original name of PT Vidya Cipta Leasing Corporation on Aug 13th, 1983, then changed to PT Lautan Berlian Leasing at 1990. On 1996 company's name changed to PT Gracia Dinamika Mulifinance and in 1997 the name changed to PT Mandala Multifinance.The articles of association has been amended most recently by notarial deed no 34 dated 28 Apr 2005 concerning among others, the change in the company's name and public offering of stock.
Read more on MFIN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
